| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 08/21/2003 | US20030157505 Complexing; immobilization of active material drug |
| 08/21/2003 | US20030157487 Nucleic acid ligands |
| 08/21/2003 | US20030157191 Administering to a subject undergoing chemotherapy an amount of a chemoprotectant |
| 08/21/2003 | CA2476282A1 Dosing regimen for gemcitabine hcv therapy |
| 08/21/2003 | CA2476279A1 Modified fluorinated nucleoside analogues |
| 08/20/2003 | EP1212326A4 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 08/20/2003 | EP1189908B1 Indolocarbazole alkaloids from a marine actinomycete |
| 08/20/2003 | EP0843684B1 Universal solid supports and methods for their use |
| 08/20/2003 | CN1436787A Antibiotic and its prepn and application |
| 08/19/2003 | US6608213 Fluorescence-labeled probe for DNA and a fluorescence-labeled plasmid |
| 08/19/2003 | US6608186 Pyranosyl nucleic acid conjugates |
| 08/19/2003 | US6608036 Oligonucleotide N3′→P5′ thiophosphoramidates: their synthesis and administration to treat neoplasms |
| 08/19/2003 | US6607741 Conjugates of sodium channel blockers and methods of using the same |
| 08/14/2003 | WO2003066878A2 Nucleic acid analysis using layered expression scanning |
| 08/14/2003 | WO2003066645A2 Base-labeled nucleosides and nucleotides |
| 08/14/2003 | WO2003066633A1 Novel pyranosyl cytosines: pharmaceutical formulations and methods |
| 08/14/2003 | WO2003012051A8 Inhibitor of dna methylation |
| 08/14/2003 | US20030153745 Process for producing nucleic acid derivative |
| 08/14/2003 | US20030153744 Such as 4-amino-7-(2'deoxy,-beta-l-erythro-pento-furanosyl) pyrrolo(2,3-D)pyrimidine for treatment of hepatitis B virus infection with reduced side effects |
| 08/14/2003 | US20030153742 Mixing with nonionic surfactants to form imine linkages with contaminants in solvent |
| 08/13/2003 | EP1334978A1 Process for preparing nucleic acid derivative |
| 08/13/2003 | EP1334111A2 Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge |
| 08/13/2003 | EP1334109A2 Improved synthesis of purine locked nucleic acid analogues |
| 08/13/2003 | EP1333826A2 Phase transfer catalyzed glycosidation of an indolocarbazole |
| 08/13/2003 | CN1436082A 3'-or 2'-hydroxymethyl substd. nucleoside derivs. for treatment of hepatitis virus infections |
| 08/13/2003 | CN1117872C Method of producing derivs. of lactosamine |
| 08/13/2003 | CN1117751C Antiviral nucleoside analogues |
| 08/12/2003 | US6605611 Nucleoside and nucleotide analogues labelled with a reporter moiety |
| 08/12/2003 | US6605597 Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives |
| 08/12/2003 | US6605596 Indolocarbazole anticancer agents and methods of using them |
| 08/12/2003 | US6605299 Releasable linkage and compositions containing same |
| 08/07/2003 | WO2003064626A2 Double-stranded oligonucleotides |
| 08/07/2003 | WO2003064625A2 Oligonucleotide compositions with enhanced efficiency |
| 08/07/2003 | WO2003063771A2 N4-acylcytosine nucleosides for treatment of viral iinfections |
| 08/07/2003 | WO2003000271A8 System and method for the large scale labeling of compounds with radiohalogens |
| 08/07/2003 | WO2002100415A3 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus |
| 08/07/2003 | WO2001073095A3 Preparation of deoxynucleosides |
| 08/07/2003 | US20030149261 2'/3'-O-acetyl-ADP-ribose is produced by reacting Sir2 enzymes with acetylated peptide substrate (p53 genes) and NAD+; anticancer agents |
| 08/07/2003 | US20030149050 Inhibitors of inflammation and reperfusion injury and methods of use thereof |
| 08/07/2003 | US20030148991 Use of at least one lipoic acid, of a physiologically acceptable derivative and/or salt thereof and at least one C1 donor for producing formulation for C1 donor-assisted therapy of central nervous system disorders |
| 08/07/2003 | US20030148967 For prophylaxis and therapy of viral infection for example by varicella zoster virus (VZV) |
| 08/07/2003 | US20030148470 Propargylethoxyamino nucleotides |
| 08/07/2003 | US20030147845 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 08/07/2003 | CA2475003A1 Double-stranded oligonucleotides |
| 08/07/2003 | CA2474910A1 Oligonucleotide compositions with enhanced efficiency |
| 08/06/2003 | EP1332150A1 Modified nucleosides and nucleotides and use thereof |
| 08/06/2003 | EP1090022B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 08/06/2003 | EP1062840A4 Apparatus and method for a custom soft-solid hearing aid |
| 08/06/2003 | EP1060639A4 Compliant hearing aid and method of manufacture |
| 08/06/2003 | EP0994890B1 Benzimidazole derivatives |
| 08/06/2003 | CN1434830A 2-aminocarbonyl-9H-punine derivatives |
| 08/06/2003 | CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 08/06/2003 | CN1434723A Immunostimulatory oligodeoxynucleotides |
| 08/05/2003 | US6602858 Ribozyme for use as tool in genetic engineering |
| 07/31/2003 | WO2003062783A2 Light addressable electrochemical detection of duplex structures |
| 07/31/2003 | WO2003062445A2 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis |
| 07/31/2003 | WO2003062257A1 Deazapurine nucleoside analogs and their use as therapeutic agents |
| 07/31/2003 | WO2003062256A1 2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents |
| 07/31/2003 | WO2003062255A2 Sugar modified nucleosides as viral replication inhibitors |
| 07/31/2003 | WO2003062212A1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 07/31/2003 | WO2003061670A1 Compounds useful as a3 adenosine receptor agonists |
| 07/31/2003 | WO2003061576A2 Deazapurine nucleoside analogs and their use as therapeutic agents |
| 07/31/2003 | WO2003061568A2 Methods and therapeutic compositions in the treatment of advanced cancer |
| 07/31/2003 | WO2003061385A1 Tricyclic nucleoside library compounds, synthesis, and use as antiviral agents |
| 07/31/2003 | US20030144502 Induce apoptosis; anticancer agents |
| 07/31/2003 | US20030144501 Conformationally constrained L-nucleosides |
| 07/31/2003 | US20030144499 Photocleavable protecting groups and methods for their use |
| 07/31/2003 | US20030144243 Combination of a crystalline drug form and atiotropium salt |
| 07/31/2003 | US20030144235 Anticarcinogenic agents for treating cancer, a viricides for viral diseases, inhibit DNA replication |
| 07/31/2003 | US20030143708 Method and reagent for the treatment of alzheimer's disease |
| 07/31/2003 | US20030143599 Attaching a primer; ligation of an adaptor sequence or homopolymeric tailing with terminal deoxynucleotidyltransferase |
| 07/31/2003 | US20030143581 Target analyte supported on conductive support containing a nanoparticle comprising a photoelectrochemically active group, exposing the active group with light to generate photoelectric current, measuring the current |
| 07/31/2003 | US20030143561 Nucleoside derivatives for library preparation |
| 07/31/2003 | US20030143282 Adenosine A3 receptor agonist |
| 07/31/2003 | CA2474337A1 Compounds useful as a3 adenosine receptor agonists |
| 07/31/2003 | CA2473960A1 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis |
| 07/30/2003 | EP1330550A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 07/29/2003 | US6600031 Methods of making nucleic acid or oligonucleotide arrays |
| 07/29/2003 | US6600028 Tricyclic base analogues |
| 07/29/2003 | US6599887 Methods of treating viral infections using antiviral liponucleotides |
| 07/24/2003 | WO2003059925A1 Calix[4]arene-nucleoside and calix[4]arene-oligonucleotide hybrids |
| 07/24/2003 | WO2003038117A3 Enhanced in vitro nucleic acid synthesis using nucleoside monophosphates |
| 07/24/2003 | WO2003011221A3 PREPARATION AND USE OF α-KETO PHOSPHONATES |
| 07/24/2003 | US20030139601 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests |
| 07/24/2003 | US20030139593 Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine |
| 07/24/2003 | US20030139586 C3' -methylene hydrogen phosphonate oligomers and related compounds |
| 07/24/2003 | US20030139369 Antiinflammatory agents; respiratory system disorders |
| 07/24/2003 | US20030138797 Phosphoramidate compounds/libraries as nucleoside/ oligonucleotide therapeutic agents; capture probes; for treatment of infection by hepadnavirus; drug screening |
| 07/23/2003 | EP1329220A1 Cytokine related treatments of disease |
| 07/23/2003 | EP0811011B1 Carbohydrate conjugated bio-active compounds |
| 07/23/2003 | CN1432020A 嘌呤衍生物 Purine derivatives |
| 07/23/2003 | CN1431907A Method of treating hepatitis delta viral infection |
| 07/23/2003 | CN1115152C Method for treating bronchitis with uridine triphosphates and related compounds |
| 07/22/2003 | US6596859 Generation of preferential nucleoside; obtain chemical intermediates, effect condensation reaction, acylate product, mix with pyridine and thionyl chloride, recover nucleoside |
| 07/22/2003 | US6596858 Process for the production of 2-halo-6-aminopurine derivatives |
| 07/22/2003 | US6596857 Preparation of phosphorothioate oligomers |
| 07/22/2003 | US6596856 Nucleic acid labeling compounds |
| 07/22/2003 | US6596725 Vision defects |
| 07/22/2003 | US6596720 Potentiating an anti-HIV activity of trifluridine and derivatives in thereof in a mammal, including human, comprising administering to said mammal, including human, an effective amount of a thymidine phosphorylase inhibitor and |
| 07/22/2003 | US6596700 Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosides |